Coronavirus disease 2019: the harms of exaggerated information and non-evidence-based measures.

A new interesting article has been published in Eur J Clin Invest. 2020 Mar 23:e13223. doi: 10.1111/eci.13223. [Epub ahead of print] and titled:

Coronavirus disease 2019: the harms of exaggerated information and non-evidence-based measures.

Authors of this article are:

Ioannidis JPA.

A summary of the article is shown below:

The evolving coronavirus disease 2019 (COVID-19) pandemic1 is certainly cause for concern. Proper communication and optimal decision-making is an ongoing challenge, as data evolve. The challenge is compounded, however, by exaggerated information. This can lead to inappropriate actions. It is important to differentiate promptly the true epidemic from an epidemic of false claims and potentially harmful actions.This article is protected by copyright. All rights reserved.

Check out the article’s website on Pubmed for more information:

[link-preview url=https://www.ncbi.nlm.nih.gov/pubmed/32202659 forceshot=true]

This article is a good source of information and a good way to become familiar with topics such as: COVID-19; SARS-COV-2; 2019-nCoV; Coronavirus.


New Research Kits from MOLECULAR DEPOT


New Antibodies from MOLECULAR DEPOT


New Proteins from MOLECULAR DEPOT


New Chemicals from MOLECULAR DEPOT

Molecular Depot

Your specialty peptide, proteins, antibodies and chemical compounds store.